VHL and breast cancer: The silencing of miR-429, by regulating cell proliferation and invasion by targeting VHL mRNA, could be proposed a new anti-proliferative and anti-metastatic therapeutic strategy, alone or in combination with other drugs, for HER2+ BC patients' treatment.